Literature DB >> 12175769

Encapsulated cell technology: from research to market.

Gorka Orive1, Rosa María Hernández, Alicia R Gascón, Manoli Igartua, José Luis Pedraz.   

Abstract

Encapsulated cell technology has the potential to treat a wide range of diseases by the controlled and continuous delivery of biological products to the host. Many biotechnology companies have focused their interest in this technology taking into account the promising pre-clinical and clinical results and the potential clinical market. However, on the long way from clinic to market several issues will have to be addressed, including suitable scientific development, ethical obstacles, government regulations and market forces.

Mesh:

Substances:

Year:  2002        PMID: 12175769     DOI: 10.1016/s0167-7799(02)02037-1

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  3 in total

Review 1.  Controlled delivery systems: from pharmaceuticals to cells and genes.

Authors:  Elizabeth Rosado Balmayor; Helena Sepulveda Azevedo; Rui L Reis
Journal:  Pharm Res       Date:  2011-03-19       Impact factor: 4.200

2.  Microtube Array Membrane (MTAM)-Based Encapsulated Cell Therapy for Cancer Treatment.

Authors:  Chee Ho Chew; Chih-Wei Lee; Wan-Ting Huang; Li-Wei Cheng; Amanda Chen; Tsai-Mu Cheng; Yen-Lin Liu; Chien-Chung Chen
Journal:  Membranes (Basel)       Date:  2020-04-26

3.  Transgenic pigs with pancreas-specific expression of green fluorescent protein.

Authors:  Hitomi Matsunari; Toshihiro Kobayashi; Masahito Watanabe; Kazuhiro Umeyama; Kazuaki Nakano; Takahiro Kanai; Taisuke Matsuda; Masaki Nagaya; Manami Hara; Hiromitsu Nakauchi; Hiroshi Nagashima
Journal:  J Reprod Dev       Date:  2014-04-21       Impact factor: 2.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.